Free Newsletter
Researcher touts new work on insulin-producing cells
Wendy Macfarlane of Britain's Brighton University told an international diabetes conference in South Africa that new work in the field indicates that efforts to make both embryonic and adult stem cells produce insulin can lead to animal studies of a replacement beta cell by the turn of the decade. The goal is to develop an insulin producing cell that can respond to the fluctuation of glucose levels in the body. Diabetes kills 3.8 million people every year and has been growing at epidemic rates. In another 20 years diabetes could afflict 380 million people if no cure is found.
- read the AFP report on diabetes research
Related Article:
Team coaxes stem cells to produce insulin. Report
Researchers probe chemical link to diabetes cure. Report
Genetic variation key indicator of diabetes risk. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: